Tricida
TCDA
TCDA was delisted on the 23rd of January, 2023.
45 hedge funds and large institutions have $786M invested in Tricida in 2018 Q2 according to their latest regulatory filings, with 45 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
67.76% more ownership
Funds ownership: 0% → 67.76% (+68%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OrbiMed
New York
|
+$304M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$84.4M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$44.7M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$31.2M |
| 5 |
Avoro Capital Advisors
New York
|
+$30.6M |
Top Sellers
TCDA Hedge Fund Activity: Q2 2018 in Review
45 of the 4,387 institutional investors tracked by Wall St. Rank reported a position in Tricida (TCDA) for Q2 2018, worth a combined $786M.
Buyers outnumbered sellers: 45 funds opened new TCDA positions and 0 closed out — a net gain of 45 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was OrbiMed, opening a new position worth an estimated $304M.
- 45 institutional investors held Tricida (TCDA) as of Q2 2018, up from 0 in Q1 2018.
- Funds reported $786M of Tricida stock for Q2 2018.
- 45 funds opened new Tricida positions in Q2 2018 and 0 closed out, a net change of +45 holders.
- The largest Tricida buyer in Q2 2018 was OrbiMed, an estimated $304M added.
Based on aggregated 13F filings for Q2 2018.